12-57569648-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_004984.4(KIF5A):c.1082C>T(p.Ala361Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004984.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000283 AC: 7AN: 247476Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134290
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461702Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727122
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74464
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 10 Pathogenic:1
- -
not specified Uncertain:1
Variant summary: KIF5A c.1082C>T (p.Ala361Val) results in a non-conservative amino acid change located in the coiled-coil coding region (neck region of the protein, Lo_2006 and Goizet_2009) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 249638 control chromosomes (gnomAD and publications). c.1082C>T has been reported in the literature in at least one individual affected with late-onset autosomal dominant hereditary spastic paraparesis without familial segregation analysis (Lo_2006). In addition, the variant was detected in an individual with primary progressive multiple sclerosis (PPMS) and an individual with relapsing multiple sclerosis (RMS) (Jia_2018). These data do not allow any conclusion about variant significance. At least one functional study reports that this variant did not change the gliding properties of the protein (microtubule affinity or gliding velocity) in vitro (Ebbing_2008). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance until additional evidence becomes available. -
KIF5A-related disorder Uncertain:1
The KIF5A c.1082C>T variant is predicted to result in the amino acid substitution p.Ala361Val. This variant was reported in individuals with spastic paraplegia and also in an individual with primary progressive multiple sclerosis (Lo Giudice et al. 2006. PubMed ID: 16476820; Ebbing et al. 2008. PubMed ID: 18203753; Jia et al. 2018. PubMed ID: 29908077). In an in vitro functional assay designed to model kinesin-1 (KIF5A) transport activity (multiple motor gliding assays), there was no difference between p.Ala361Val and wild-type activity (Ebbing et al. 2008. PubMed ID: 18203753). This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-57963431-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
KIF5A: PP2 -
Spastic paraplegia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at